Titlebook: Chemoradiation in Cancer Therapy; Hak Choy Book 2003 Springer Science+Business Media New York 2003 breast cancer.cancer.carcinoma.chemothe

Conjecture

書目名稱Chemoradiation in Cancer Therapy影響因子(影響力)




書目名稱Chemoradiation in Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Chemoradiation in Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Chemoradiation in Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Chemoradiation in Cancer Therapy被引頻次




書目名稱Chemoradiation in Cancer Therapy被引頻次學(xué)科排名




書目名稱Chemoradiation in Cancer Therapy年度引用




書目名稱Chemoradiation in Cancer Therapy年度引用學(xué)科排名




書目名稱Chemoradiation in Cancer Therapy讀者反饋




書目名稱Chemoradiation in Cancer Therapy讀者反饋學(xué)科排名

起波瀾

灰姑娘

reflection

五行打油詩

Indicative

The Role of Gemcitabine in Combined Modality Therapyon in pancreatic carcinoma, gemcitabine has been licensed for the treatment of nonsmall-cell lung cancer (NSCLC) .. The focus of this chapter will be to examine the current preclinical and clinical evidence probing the efficacy of gemcitabine as a clinically useful radiosensitizing agent. It will be

Indicative

勤勉

Combined Modality Strategies in the Treatment of Head and Neck Cancerr Society estimates that in the United States alone approx 40,300 new cases of HNC will be diagnosed annually with approx 11,700 deaths associated from this disease .. If cured, HNC patients are at increased risk of developing a second malignancy, estimated to occur at an annual incidence of 3–7% (3

Traumatic-Grief

The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer 131,000 new cases of nonsmall-cell lung cancer (NSCLC) diagnosed in 2000 will die from their disease .. The focus of this chapter is on the patients who present with locally advanced or stage III NSCLC (about 46,000 patients yearly). Although it is tempting to think of stage III NSCLC as a uniform

半身雕像